AGC Core Services manager Daniel Hernandez Armada has co-authored a paper on “Enzymatic conversion of lactose into galacto-oligosaccharides” that has been accepted for publication in the Journal of Food Engineering. Click here for PDF version.
Pleased to report that the European Patent Office (EPO) has issued a decision to grant a European patent pursuant to Article 97(1) EPC to our technology titled “Methods and Systems for O-Glycosylating Proteins.” Another successful development in our IP portfolio. Congratulations to all involved with developing and guiding this technology through the patent process.
A field at the forefront of biomedical science, glycosciences is the study of complex roles for carbohydrates–also described as oligosaccharides or glycans–in biological systems. Going far beyond a role as an energy source, carbohydrates orchestrate many critical cellular processes, all the way from fertilization to programmed cell death. Click here for full article. Published originally by U of A Faculty of Science on November 2, 2017
The Klassen group currently has vacancies for two PhD and one post-doctoral specialists in biomolecular mass spectrometry and functional glycomics. For more information on these positions please contact Dr. John Klassen.
“A University of Alberta biotechnology spinoff wants to put Edmonton at the epicentre of molecular discoveries by creating an immense searchable database that could speed up and drive down the cost of research and development.” Click here for the full article in the Edmonton Journal.
The Alberta Glycomics Centre is proud to support the launch of biotech spin-off company 48Hour Discovery Inc., an Alberta-based company providing services in ligand discovery in unprecedented turnaround time and within a fully manageable costing model. Founded in February 2017, 48HD’s core business is rooted in a proprietary molecular discovery platform emanating from the expertise and intellectual property generated from the Derda Research Group under the AGC research and commercialization umbrella. The company provides rapid ligand discovery services for any target using its expansive portfolio of genetically-encoded molecules, mining technology, and a standardized discovery protocol. More to follow on this…
AGC Director Dr. John Klassen’s co-authored article “Investigating the Influence of Membrane Composition on Protein-Glycolipid Binding Using Nanodiscs and Proxy Ligand ESI-MS” has been accepted for publication in Analytical Chemistry. Watch this site for updates and links.
AGC Director Dr. John Klassen’s co-authored article “High Throughput, Label- and Immobilization-Free Screening of Human Milk Oligosaccharides Against Lectins” has been accepted for publication in Analytical Chemistry. Watch this site for updates and links.